US Patent Issued to GFB (ABC) on June 16 for "Crystal forms of a pyridazinone TRPC inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,132, issued on June 16, was assigned to GFB (ABC) LLC (Foxboro, Morocco).

"Crystal forms of a pyridazinone TRPC inhibitor" was invented by Wenfeng Xue (Suzhou, China) and Yuejun Gao (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are crystalline forms of Compound 100. In some embodiments, a crystalline form of Compound 100 has characteristic peaks in the XRPD pattern as shown in any one of FIGS. 1A, 2A, 3A, 4A, 5A, and 6A."

The patent was filed on April 10, 2020, under Application No. 17/603,249.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2...